ADNP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.63770038933365E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.197800E-04 |
Normal-vs-Stage2 |
3.52750000000013E-05 |
Normal-vs-Stage3 |
6.85251855259139E-12 |
Normal-vs-Stage4 |
1.55060408957297E-11 |
Stage1-vs-Stage2 |
1.067420E-01 |
Stage1-vs-Stage3 |
4.45639999999692E-05 |
Stage1-vs-Stage4 |
6.35139999999312E-05 |
Stage2-vs-Stage3 |
2.256600E-01 |
Stage2-vs-Stage4 |
7.478500E-02 |
Stage3-vs-Stage4 |
3.776000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.1492999885121E-09 |
Normal-vs-AfricanAmerican |
3.99790000005229E-06 |
Normal-vs-Asian |
9.029900E-02 |
Caucasian-vs-AfricanAmerican |
5.508800E-01 |
Caucasian-vs-Asian |
6.862000E-01 |
AfricanAmerican-vs-Asian |
4.914600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.89339663339661E-11 |
Normal-vs-Female |
8.15430000000728E-05 |
Male-vs-Female |
1.323700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.3436999999914E-06 |
Normal-vs-Age(41-60Yrs) |
4.10940000028504E-07 |
Normal-vs-Age(61-80Yrs) |
1.31599997565957E-09 |
Normal-vs-Age(81-100Yrs) |
3.648300E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.528600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.285400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.847000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.182800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.898400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.748400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.227000E-01 |
Normal-vs-Grade 2 |
4.447800000007E-05 |
Normal-vs-Grade 3 |
2.03909999996199E-09 |
Normal-vs-Grade 4 |
2.26485497023532E-14 |
Grade 1-vs-Grade 2 |
5.097600E-02 |
Grade 1-vs-Grade 3 |
8.802500E-03 |
Grade 1-vs-Grade 4 |
2.2283999999928E-05 |
Grade 2-vs-Grade 3 |
1.595560E-02 |
Grade 2-vs-Grade 4 |
7.47960000047065E-07 |
Grade 3-vs-Grade 4 |
1.940020E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.704400E-02 |
Normal-vs-ccB subtype |
1.92068583260152E-14 |
ccA subtype-vs-ccB subtype |
1.64469993180205E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.70299999949719E-08 |
Normal-vs-N1 |
6.320900E-03 |
N0-vs-N1 |
2.699000E-01 |
|
|